The trend toward lower CK-MB levels in selenium-treated patients must be interpreted with caution, as it did not reach statistical significance, was not observed in the parent trial and was not accompanied by a reduction in clinically meaningful outcome parameters.
← all excerpts
Perioperative high-dose selenium supplementation in open thoracic aortic surgery: a post hoc subgroup analysis of the SUSTAIN CSX trial.
1
—
—